Gene expression signatures for prognosis in NSCLC, coupled with signatures of oncogenic pathway deregulation, provide a novel approach for selection of molecular targets.

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Petersen, RP; Bild, A; Dressman, H; Joshi, MBM; Conlon, DH; West, M; Nevins, JR; Harpole, DH

Published Date

  • June 1, 2005

Published In

Volume / Issue

  • 23 / 16

Start / End Page

  • 626S - 626S

Published By

Pages

  • 1

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Conference Name

  • 41st Annual Meeting of the American-Society-of-Clinical-Oncology

Conference Location

  • Orlando, FL

Conference Start Date

  • May 13, 2005

Conference End Date

  • May 17, 2005